Gene Therapy Affordability in Denmark Quiz
10 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a key concern for gene therapy treatment in Denmark?

  • Affordability issues arising from individual hospitals being responsible for delivering specialist treatment (correct)
  • Lack of availability of gene therapy treatment in Denmark
  • Lack of network of specialist centers for gene therapy treatment
  • Government regulations restricting gene therapy treatment

    • Who is responsible for covering the treatment costs for gene therapy and ATMPs in Denmark?

  • Patients themselves
  • Pharmaceutical companies
  • Hospitals and health insurers (correct)
  • The government

    • What approach has Denmark taken to handle equity concerns for gene therapy treatment?

  • Limiting access to gene therapy treatment based on regions
  • Relying solely on government funding for gene therapy treatment
  • Privatizing gene therapy treatment centers
  • Built-in service preparation requirements in a joint horizon scanning process at the Nordic level (correct)

    • What is the current status of market authorization for Fidanacogene elaparvovec in Denmark?

    <p>It has yet to get approval for market authorization</p> Signup and view all the answers

    What burden will be felt by a small number of centers in Denmark in relation to gene therapy treatment?

    <p>Reconfiguring services for gene therapy treatments</p> Signup and view all the answers

    What are the affordability issues specific to gene therapy and ATMPs in Denmark?

    <p>Individual hospitals are responsible for delivering specialist treatment, which is funded by hospitals. The potential availability of specialist funds for ATMPs is uncertain, leaving hospitals and health insurers to cover treatment costs.</p> Signup and view all the answers

    What network does Denmark have to treat patients with ATMPs?

    <p>Denmark has a network of specialist centers that can treat patients with ATMPs.</p> Signup and view all the answers

    How has Denmark addressed equity concerns for gene therapy treatment?

    <p>Denmark has built-in service preparation requirements in a joint horizon scanning process at the Nordic level, and identified infrastructure and services that can be reconfigured for ATMPs.</p> Signup and view all the answers

    What is a key challenge faced by a small number of centers in Denmark in relation to gene therapy treatment?

    <p>The burden of reconfiguring services for these treatments will be felt by a small number of centers.</p> Signup and view all the answers

    What is the current status of market authorization for Fidanacogene elaparvovec in Denmark?

    <p>Fidanacogene elaparvovec has yet to get approval for market authorization, therefore currently.</p> Signup and view all the answers

    More Like This

    Gene Therapy
    24 questions

    Gene Therapy

    HonestSynergy avatar
    HonestSynergy
    Gene Therapy vs
    5 questions

    Gene Therapy vs

    NiftySilver avatar
    NiftySilver
    Understanding Gene Therapy and the Human Genome
    25 questions

    Understanding Gene Therapy and the Human Genome

    ProsperousCherryTree avatar
    ProsperousCherryTree
    Vector Properties in Gene Therapy Quiz
    16 questions

    Vector Properties in Gene Therapy Quiz

    EuphoricWeasel avatar
    EuphoricWeasel
    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser